23rd Annual Biotech in Europe Forum

FOR GLOBAL PARTNERING & INVESTMENT

20th - 21st of September 2023|MÖVENPICK HOTEL | BASEL | SWITZERLAND

SILVER SPONSORS:

Basel+ Logo

Basel+

The Canton of Basel-Stadt contributes to the further development of convention-related tourism. Conventions are specifically acquired, developed and held, thus accessing a potential not yet exploited with benefits beyond tourism. The objective of convention promotion is to increase the direct and indirect added value generated by conventions. Additionally, a further strengthening of Basel as the most innovative economic location and center of knowledge in Switzerland is targeted. By promoting conventions, we want to contribute to Basel remaining one of the most important trade fair and convention cities in Europe.
Stifel Logo

Stifel

Stifel is a full-service investment bank with deep industry experience. We serve as strategic advisors to entrepreneurs, family-owned businesses, private equity groups, and leading public and private corporations in North America, Europe, Asia, and Latin America. Our full-service healthcare investment banking practice offers a best-in-class combination of deep sector knowledge, strong industry relationships, and broad product expertise. We are not bound by borders. We stand ready to provide the insight and expertise you require. Our integrated approach allows us to deliver the full capabilities of Stifel’s institutional capital markets platform and retail brokerage network, which are among the most highly regarded in the industry.

BRONZE SPONSORS:

InvestHK Logo

InvestHK

InvestHK’s vision is to strengthen Hong Kong’s status as the leading international finance and business hub. Our mission is facilitate and promote economically and strategically important investment, both inward and outward, to support the economic development of Hong Kong.
Merck KGaA Logo

Merck KGaA

We are Merck KGaA, Darmstadt, Germany, a vibrant science and technology company.

Science is at the heart of everything we do. It drives the discoveries we make and the technologies we create.

The passion of our curious minds makes a positive difference to millions of people’s lives every day.

In Healthcare, we discover unique ways to treat the most challenging diseases, such as multiple sclerosis and cancer. Our Life Science experts empower scientists by developing tools and solutions that help deliver breakthroughs more quickly. And in Electronics, we develop science that sits inside technologies and changes the way we access, store, process, and display information.

Everything we do is fueled by a belief in science and technology as a force for good. A belief that has driven our work since 1668 and will continue to inspire us to find more joyful and sustainable ways to live.

We are curious minds dedicated to human progress.

CONTRIBUTING SPONSORS:

Canton of Basel-Stadt Logo

Canton of Basel-Stadt

An economic powerhouse situated on the border of three countries, Basel-Stadt offers a very dynamic business environment. A healthy ecosystem thrives on its diversity to enrich and pollinate each other. Existing blue-chip companies, international companies that settle here, leading research institutes and SME’s rub shoulders with vibrant startups, prolific incubators and multinationals which thrive in the area. Born in the nucleus of life sciences innovation, Basel-Stadt flourishes as an international hub of innovation, culture and business acumen.
 
Switzerland is considered the most innovative country in the world, according to a number of studies. Access to knowledge, highly qualified and international talent and a supportive government have turned Basel into the leading innovation hub of Switzerland. A future-oriented outlook with continuous innovation marks Basel as an international leader in life sciences, healthcare, ICT technology and circular economy.

With a population of 200,000, Basel may seem to be a small city, but its rich economic and cultural offerings put it firmly in the big league. Many international companies and well-known brands such as Novartis, Roche, Lonza, Moderna, BeiGgene, Bayer and Syngenta have their headquarters here, and the city has a thriving, multi-cultural, well-educated expat community coming from more than 160 different countries.

Latham & Watkins LLP Logo

Latham & Watkins LLP

Latham & Watkins LLP is one of the largest law firms in the world with more than 3,000 lawyers located in major financial, business and regulatory centers around the globe. Our award-winning Healthcare & Life Sciences Industry guides clients through their most significant and cutting-edge legal challenges through a combination of in-depth industry knowledge, legal acumen, and strategic business advice. We understand the unique economic, market, regulatory and political climates in which healthcare and life sciences companies operate.
Novo Holdings A/S Logo

Novo Holdings A/S

Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation. The purpose of Novo Holdings is to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. Wholly owned by the Novo Nordisk Foundation, Novo Holdings is the controlling shareholder of Novo Nordisk and Novonesis and manages an investment portfolio with a long-term return perspective. In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure and private equity assets, Novo Holdings is a world-leading life sciences investor. Through its Seed, Venture, Growth, Principal Investments, Planetary Health Investments and Asia teams, Novo Holdings invests in life science companies at all stages of development. As of year-end 2023, Novo Holdings had total assets of EUR 149 billion.
PharmaVentures Ltd. Logo

PharmaVentures Ltd.

PharmaVentures is a premier transaction advisory firm and a leading international company in partnering, M&A deals and strategic alliances. For over 30 years, PharmaVentures has acted as advisor on over 1000 deal related projects covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies worldwide. PharmaVentures’ deep bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes it uniquely placed to support business in all aspects of deal making and strategic planning. PharmaVentures is well known for its deep insight into deal structures and its success for generating partnering interest. PharmaVentures’ services include: · M&A (divestments, mergers, acquisitions, and strategic transactions) · Licensing (in and out licensing) · Fundraising Support · Strategy (commercialisation, deal strategy, due diligence, market entry) · Valuations (licensing, M&A and fundraising) · Pricing and Market Access PharmaVentures is based in London, UK, and employs over 30 professionals and has associates in Asia-Pacific. PharmaVentures Capital Ltd is a wholly owned subsidiary of PharmaVentures Ltd. All regulated activities are delivered through PharmaVentures Capital Ltd, which is authorised and regulated by the Financial Conduct Authority (741356).